设为首页 加入收藏

TOP

TEPADINA 15 mg powder for concentrate for solution for infusion(八)
2018-01-24 02:34:52 来源: 作者: 【 】 浏览:7950次 评论:0
estinal perforation
Ileus
 Gastrointestinal ulcer
Hepatobiliary disorders
 Venoocclusive liver disease
Hepatomegaly
Jaundice
Skin and subcutaneous tissue disorders
 Rash
Pruritus
Alopecia
 Erythema
 Pigmentation disorder
Erythrodermic psoriasis
 Severe toxic skin reactions including cases of Stevens-Johnson syndrome and toxic epidermal necrolysis
Musculoskeletal and connective tissue disorders
 Back pain
Myalgia
Arthralgia
Renal and urinary disorders
 Cystitis haemorrhagic
 Dysuria
Oliguria
Renal failure
Cystitis
Haematuria
Reproductive system and breast disorders
 Azoospermia
Amenorrhoea
Vaginal haemorrhage
 Menopausal symptoms
Infertility female
Infertility male
General disorders and administration site conditions
 Pyrexia
Asthenia
Chills
Generalised oedema
Injection site inflammation
Injection site pain
Mucosal inflammation
 Multi-organ failure
Pain
Investigation
 Weight increased
Blood bilirubin increased
Transaminases increased
Blood amylase increased
 Blood creatinine increased
Blood urea increased
Gamma-glutamyltransferase increased
Blood alkaline phosphatase increased
Aspartate aminotransferase increased
Paediatric population
The adverse reactions considered at least possibly related to conditioning treatment including thiotepa, reported in paediatric patients as more than an isolated case, are listed below by system organ class and by frequency. Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Frequencies are defined as: very common (≥1/10), common ((≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000) very rare (<1/10,000), not known (cannot be estimated from the available data).
System organ class
 Very common
 Common
 Not known
Infections and infestations
 Infection susceptibility increased
Sepsis
 Thrombocytopenic purpura
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
 Treatment related second malignancy
Blood and lymphatic system disorders
 Thrombocytopenia
Febrile neutropenia
Anaemia
Pancytopenia
Granulocytopenia
Immune system disorders
 Acute graft versus host disease
Chronic graft versus host disease
Endocrine disorders
 Hypopituitarism
Hypogonadism
Hypothyroidism
Metabolism and nutrition disorders
 Anorexia
Hyperglycaemia
Psychiatric disorders
 Mental status changes
 Mental disorder due to a general medical condition
Nervous system disorders
 Headache
Encphalopathy
Convulsion
Cerebral haemorrhage
Memory impairment Paresis
 Ataxia
 Leukoencephalopathy
Ear and labyrinth disorders
 Hearing impaired
Cardiac disorders
 Cardiac arrest
 Cardiovascular insufficiency
Cardiac failure
Vascular disorders
 Haemorrhage
 Hypertension
Respiratory, thoracic and mediastinal disorders
 Pneumonitis
 Idiopathic pneumonia syndrome
Pulmunary haemorrage
Pulmonary oedema
Epistaxis
Hypoxia
Respiratory arrest
 Pulmonary arterial hypertension
Gastrointestin
以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 5 6 7 8 9 10 11 下一页 尾页 8/13/13
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇INCIVO*FL 168CPR RIV 375MG 下一篇TEPADINA 100 mg powder for conc..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位